Clinical study on changes in blood uric acid levels after switching from existing uric acid lowering drugs to URECE tablets (preliminary test)
Not Applicable
- Conditions
- Hyperuricemia
- Registration Number
- JPRN-UMIN000046735
- Lead Sponsor
- Takasaki University of Health and Welfare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
If the subject feels that the research itself is a burden to his/her daily life. Subjects who are judged by the principal investigator or sub-investigator to be ineligible for the study. Those who have contraindications to the administration of the study drug URECE Tablets used in the study. Those who have gout attack. Patients with urinary tract stones, or patients with a history of urinary tract stones. Patients with severe hepatic or renal impairment or cardiac disease. Pregnant women and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method